The reaction of nicotinic and isonicotinic propargylamides with lipophilic aliphatic amines yielded a series of 3- or 4-(5-methyl-1H-imidazol-2-yl)pyridines containing a lipophilic substituent in the imidazole ring 1-position. The new compounds were characterized by physicochemical methods. The antituberculosis and antimicrobial activities against ESKAPE pathogens were studied. 3-[1-(1-n-Octadecyl)-5-methyl-1Himidazol-2-yl]pyridine (IIId) had antituberculosis activity (MIC 6.2 μg/mL) while 3-[1-(1-adamantylmethyl)-5-methyl-1H-imidazol-2-yl]pyridine (IIIa) exhibited activity against S. aureus (MIC 16 μg/mL).
Similar content being viewed by others
References
Y. Q. Hu, S. Zhang, F. Zhao, et al., Eur. J. Med. Chem., 133, 255 – 267 (2017).
S. S. Swain, S. K. Paidesetty, R. N. Padhy, et al., Chem. Biol. Drug Des., 96, No. 2, 714 – 730 (2020).
V. Pflegr, J. Maixnerova, J. Stolarikova, et al., Pharmaceuticals (Basel), 14, No. 12 (2021).
S. Perveen, D. Kumari, K. Singh, et al., Eur. J. Med. Chem., 229, 114066 (2022).
G. Navarrete-Vazquez, G. M. Molina-Salinas, Z. V. Duarte-Fajardo, et al., Bioorg. Med. Chem., 15(16), 5502 – 5508 (2007).
D. Mata-Espinosa, G. M. Molina-Salinas, J. Barrios-Payan, et al., Pulm. Pharmacol. Ther., 32, 7 – 14 (2015).
R. Vosatka, M. Kratky, M. Svarcova, et al., Eur. J. Med. Chem., 151, 824 – 835 (2018).
D. Atukuri, R. Gunjal, N. Holagundi, et al., Drug Dev. Res., 82(6), 767 – 783 (2021).
E. R. Erwin, A. P. Addison, S. F. John, et al., Tuberculosis (Edinburgh, Scotland), 116, Suppl., S66-S70 (2019).
Z. S. Bhat, M. A. Rather, M. Maqbool, et al., Biomed. Pharmacother., 95, 1520 – 1534 (2017).
L. Wanka, K. Iqbal, and P. R. Schreiner, Chem. Rev., 113(5), 3516 – 3604 (2013).
S. Agarwal (ed.), Imidazole-Based Drug Discovery, Elsevier (2021).
M. Krasavin, A. Lukin, T. Vedekhina, et al., Eur. J. Med. Chem., 157, 1115 – 1126 (2018).
J. C. Palomino, A. Martin, M. Camacho, et al., Antimicrob. Agents Chemother., 46(8), 2720 – 2722 (2002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 6, pp. 18 – 23, June, 2023.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Vedekhina, T.S., Dogonadze, M.Z., Vinogradova, T.I. et al. Lipophilic Imidazolylpyridines with Antimicrobial Activity. Pharm Chem J 57, 816–821 (2023). https://doi.org/10.1007/s11094-023-02954-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02954-6